| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/21/2026 | ±1.9% | -0.5% | over-priced |
| 10/21/2025 | ±2.3% | +5.9% | under-priced |
| 07/22/2025 | ±2.5% | +1.0% | over-priced |
| 04/22/2025 | ±3.0% | +3.8% | under-priced |
| 10/22/2024 | ±2.2% | -4.0% | under-priced |
| 07/23/2024 | ±2.8% | +5.3% | under-priced |
| 04/23/2024 | ±1.9% | +7.2% | under-priced |
| 10/24/2023 | ±2.5% | -3.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.45 | $6.0B | $1.0B |
| Q4 FY2025 | $1.68 | $6.8B | $1.2B |
| Q3 FY2025 | $1.27 | $6.1B | $908M |
| Q2 FY2025 | $0.77 | $5.9B | $555M |
Danaher Corporation (DHR) reports in 37 days, with the next report estimated for 10/19/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 3.9% on average — the market has tended to under-price DHR's earnings risk. Fundamentals into the print: EPS up 9.8% year-over-year, revenue up 3.7%. QuantLogix's live 5-factor engine currently reads DHR as a neutral at 47/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →